Case Report: Anti-NMDAR Encephalitis With Anti-MOG CNS Demyelination After Recurrent CNS Demyelination

Ren, Bing-Yan1; Guo, Yi2; Han, Jing2; Wang, Qian2; Li, Zai-Wang2

2021-02-24

10.3389/fneur.2021.639265

Frontiers in Neurology   影响因子和分区

1664-2295

["Introduction: Anti-N-methyl-d-aspartate receptor (NMDAR) encephalitis, a serious neurological autoimmune disorder caused by autoantibodies with diverse clinical manifestations, may simultaneously onset with antimyelin oligodendrocyte glycoprotein (MOG) demyelination after recurrent central nervous system (CNS) demyelination.","Case Report: We present a case of anti-NMDAR encephalitis combining with anti-MOG CNS demyelination following recurrent CNS demyelination. A 38-year-old man admitted to hospital developed epileptic seizures following recurrent episodes of cross-sensory disturbance and dizziness. Magnetic resonance imaging (MRI) showed a demyelinating lesion in the right brainstem initially. Despite a good response to methylprednisolone pulse therapy at the beginning, the patient still had relapses and progression after corticosteroid reduction or withdrawal. Then brain MRI discovered new serpentine lesions involving extensive cerebral cortex on his second relapse. Repeat autoantibodies test indicated cerebrospinal fluid (CSF) NMDAR antibodies coexisted with MOG-Abs simultaneously, suggesting the diagnosis of anti-NMDAR encephalitis with anti-MOG CNS demyelination.","Results: After a definite diagnosis, the patient was treated with mycophenolate mofetil (MMF) and corticosteroid. He was discharged after his symptoms ameliorated. No neurological sequels remained, and there were no effects on his activities of daily living after 6 months of immunoregulatory therapy of MMF and corticosteroid.","Conclusion: For individuals with recurrent CNS demyelination, especially combining with cortical encephalitis, repeated detection of autoantibodies against AE, and demyelination in CSF/serum can be helpful to enable a definite early diagnosis. For patients who suffer from anti-NMDAR encephalitis combining with anti-MOG CNS demyelination, second-line immunotherapy is recommended when first-line treatment such as steroids, intravenous immunoglobulin G (IVIG) and plasma exchange has been proven ineffective to prevent the relapse of disease."]

recurrent CNS demyelination diagnosis anti-NMDAR encephalitis anti-MOG CNS demyelination therapy

SCI

英语

通讯

National Natural Science Foundation of China[81671219]

Neurosciences & Neurology

Clinical Neurology ; Neurosciences

WOS:000626761400001

FRONTIERS MEDIA SA

Web of Science

1.Nantong Univ, Affiliated Hosp 2, Nantong Peoples Hosp 1, Dept Emergency, Nantong, Peoples R China
2.Southern Univ Sci & Technol, Clin Med Coll 2, Shenzhen Peoples Hosp, Dept Neurol,Affiliated Hosp 1,Jinan Univ, Shenzhen, Peoples R China

Ren, Bing-Yan,Guo, Yi,Han, Jing,et al. Case Report: Anti-NMDAR Encephalitis With Anti-MOG CNS Demyelination After Recurrent CNS Demyelination[J]. Frontiers in Neurology,2021,12.

Ren, Bing-Yan,Guo, Yi,Han, Jing,Wang, Qian,&Li, Zai-Wang.(2021).Case Report: Anti-NMDAR Encephalitis With Anti-MOG CNS Demyelination After Recurrent CNS Demyelination.Frontiers in Neurology,12.

Ren, Bing-Yan,et al."Case Report: Anti-NMDAR Encephalitis With Anti-MOG CNS Demyelination After Recurrent CNS Demyelination".Frontiers in Neurology 12(2021).